Crosswalks

    Regulation timeline

    When the key MedTech laws, rules and standards took effect, from 1972 to the deadlines still ahead. Each milestone links to its term page for the full definition and primary sources.

    Timeline sources

    1970s

    1. US

      Anti-Kickback Statute enacted

      The Social Security Amendments of 1972 introduced criminal penalties for specified kickbacks, bribes and rebates connected with Medicare and Medicaid services.

      Source limitation: The original law establishes enactment, not every element of today's broader Anti-Kickback Statute.

    2. US

      Medical Device Amendments signed

      Expanded FDA authority over medical devices, established three risk classes and the premarket notification and approval framework.

      Official source

      Source checked:

    1980s

    1. US

      IDE regulation scheduled to take effect

      21 CFR Part 812 set the rules for investigational device exemptions, letting unapproved devices be used in clinical studies.

      Source limitation: Printed page 3732 onward. The rule states July 16, 1980 subject to OMB approval; the subsequent approval notice has not been verified.

    2. US

      CLIA '88 signed

      The Clinical Laboratory Improvement Amendments established federal quality standards for laboratories testing human specimens for diagnosis, prevention or treatment; research-only testing is outside that clinical scope.

      Official source

      Source checked:

    3. US

      Stark Law enacted

      The Ethics in Patient Referrals Act barred physician self-referral for Medicare-covered services, later expanded in 1993.

      Source limitation: The original prohibition concerned clinical laboratory services. Enactment is distinct from application, and the codified text includes later amendments.

    1990s

    1. US

      Safe Medical Devices Act signed

      Added device user reporting, postmarket surveillance authority and the Humanitarian Device Exemption.

      Source limitation: Enactment date, not a common application date for all implementing requirements.

    2. US

      HIPAA signed

      The Health Insurance Portability and Accountability Act laid the base for federal privacy and security rules for health data.

      Source limitation: HIPAA enactment, not issuance or compliance dates of the later Privacy and Security Rules.

    3. US

      Quality System Regulation takes effect

      21 CFR Part 820 added design controls to device good manufacturing practice requirements.

      Source limitation: Published October 7, 1996, effective June 1, 1997. See Section IV for design-control compliance details.

    4. US

      FDAMA creates De Novo

      The FDA Modernization Act created the De Novo route for novel low to moderate risk devices with no predicate.

      Official source

      Source checked:

    2000s

    1. US

      First device user fees (MDUFMA)

      The Medical Device User Fee and Modernization Act introduced user fees tied to FDA review performance goals, renewed every five years.

      Source limitation: Supports original enactment and the fee framework, not subsequent five-year reauthorizations.

    2. International

      IEC 62304 published

      First edition of the software life cycle standard for medical device software.

      Official source

      Source checked:

    3. US

      HITECH Act signed

      Strengthened HIPAA enforcement and introduced breach notification duties for health data.

      Official source

      Source checked:

    2010s

    1. US

      Physician Payments Sunshine Act

      Passed within the Affordable Care Act, requiring manufacturers to report payments to physicians and teaching hospitals.

      Source limitation: Enactment within the ACA, not the start of Open Payments reporting or disclosure.

    2. US

      UDI final rule published

      FDA required unique device identifiers on labels and GUDID submissions, phased in by device class.

      Official source

      Source checked:

    3. US

      NIST Cybersecurity Framework 1.0

      A voluntary framework for managing cybersecurity risk, widely used by manufacturers and hospitals. Version 2.0 followed in February 2024.

      Official source

      Source checked:

    4. International

      ISO 13485:2016 published

      The current edition of the medical device quality management system standard.

      Official source

      Source checked:

    5. US

      21st Century Cures Act signed

      Codified the Breakthrough Devices Program and clarified which software functions are not devices.

      Source limitation: Enactment, not the dates of subsequent FDA implementation or guidance.

    6. EU

      MDR and IVDR enter into force

      Regulations (EU) 2017/745 and 2017/746 replaced the device directives, with multi-year transition periods and EUDAMED.

    7. International

      Health Canada requires MDSAP

      Health Canada's CMDCAS program ended on January 1, 2019 as manufacturers of Class II, III and IV devices sold in Canada transitioned to MDSAP. Existing licence holders had to submit documented transition evidence by December 31, 2018; accepted arrangements allowed some MDSAP audits to take place during 2019.

      Source limitation: Health Canada's transition FAQ, questions 1, 3 and 8, distinguishes the January 1, 2019 program change from the December 31, 2018 evidence deadline. Question 7 exempts distributors, retailers and private-label manufacturers from needing their own MDSAP certificate, while their original equipment manufacturer remains subject to the requirements. This is a Canadian requirement, not a common implementation date for Japan or the other MDSAP countries.

    8. International

      ISO 14971:2019 published

      Third edition of the risk management standard for medical devices.

      Official source

      Source checked:

    2020s

    1. EU

      EU MDR date of application

      The MDR became generally applicable, including Article 117 for drug-device combinations, with separate conditional transition periods for eligible legacy devices.

    2. International

      IEC 81001-5-1 published

      Security activities for the health software product life cycle, now a key reference for device cybersecurity.

      Official source

      Source checked:

    3. EU

      EU IVDR date of application

      The IVDR became applicable, with staggered transition deadlines by risk class.

    4. EU

      MDR transition extended

      Regulation (EU) 2023/607 extended MDR transition periods for legacy devices to 2027 or 2028, depending on class.

      Official source

      Source checked:

    5. US

      Section 524B cyber requirements apply

      Under FDORA, submissions for cyber devices must include a cybersecurity plan, design controls and an SBOM.

      Official source

      Source checked:

    6. US

      eSTAR required for 510(k)s

      FDA began requiring 510(k) submissions in the electronic eSTAR format.

      Source limitation: FDA's page identifies October 1, 2023 as the requirement date. The guidance revision is October 2, 2023 and includes waiver and exemption criteria.

    7. EU

      EU AI Act enters into force

      Regulation (EU) 2024/1689 set risk-based rules for AI, with obligations phased in over several years.

      Source limitation: Entry into force is distinct from the phased application of AI Act obligations.

    8. US

      TCET final notice published and effective

      CMS published its final TCET procedural notice, effective the same day, for certain eligible FDA-designated Breakthrough Devices. The pathway was announced on August 7, 2024.

    9. US

      Initial final PCCP guidance for AI devices

      FDA issued its initial final AI-enabled device PCCP guidance, subsequently updated on August 18, 2025. Guidance recommendations are nonbinding.

    10. US

      Court vacates FDA LDT rule

      A federal court set aside FDA's rule that would have regulated laboratory-developed tests as devices.

      Official source

      Source checked:

    11. UK

      UK post-market surveillance rules apply

      MHRA guidance states that strengthened Part 4A PMS requirements apply to individual medical devices placed on the market or put into service in Great Britain from June 16, 2025, regardless of CE or UKCA marking. Earlier individual devices remain under prior PMS rules. Custom-made devices have a reduced set of obligations; Northern Ireland follows EU MDR and IVDR PMS requirements.

      Source limitation: MHRA explicitly states June 16, 2025. SI 2024/1368 was made December 16, 2024 and regulation 1(2) says it comes into force 6 months after the day it was made; the consolidated Part 4A annotation instead records June 17, 2025. The displayed date follows MHRA's operational guidance, not a resolution of this official one-day discrepancy. The guidance also excludes specified Secretary of State authorisations from these requirements and refers in-house manufacture to separate guidance.

    12. US

      FDA updates AI device PCCP guidance

      FDA issued updated final recommendations for predetermined change control plans for AI-enabled device software functions, replacing the December 4, 2024 version. This is guidance issuance, not a new statutory effective date.

      FDA updated PCCP guidance

      Source checked:

    13. US

      FDA implements LDT rule vacatur

      FDA published a final rule, effective the same day, restoring the pre-May 2024 wording of 21 CFR 809.3(a) following the March 31, 2025 court vacatur.

    14. US

      QMSR takes effect

      FDA's Quality Management System Regulation replaced the QSR, incorporating ISO 13485:2016 by reference.

      Official source

      Source checked:

    15. EU

      First four EUDAMED modules become mandatory

      Actor, UDI/Device, Notified Bodies & Certificates and Market Surveillance modules became mandatory, with applicable transition provisions. Market Surveillance is for competent authorities and the Commission; the remaining modules are not yet mandatory.

      European Commission EUDAMED overview

      Source checked:

    16. International

      Australian UDI first phase begins

      UDI labelling and AusUDID data requirements began for in-scope Class IIb and III devices, subject to exclusions and transition arrangements. Other classes are phased in later.

      TGA UDI commencement

      Source checked:

    17. EUUpcoming

      AI Act high-risk rules for devices

      Regulation (EU) 2026/1744 amended the AI Act timetable: Article 6(1) high-risk systems tied to Annex I products, including qualifying MDR/IVDR devices requiring third-party assessment, apply from August 2, 2028, rather than the original August 2, 2027 date.

      Source limitation: The amended August 2, 2028 deadline has not been independently verified against the operative amendment to Article 113. EUR-Lex returned no readable text during this audit; the recorded source-check date is not verification.

    Dates show when a rule was signed, published or took effect, as described. Always confirm against the official text. See also the regulator matrix.